Mammogram Guidelines Changed Again in 2026: Here’s What Women Need to Know Right Now
If you’ve been trying to keep up with mammogram recommendations lately, you’re not alone. In April 2026, one of the country’s largest medical organizations updated its guidance, and it doesn’t fully line up with what other major groups are recommending. Here’s what’s actually going on, and what it means for your next screening.
What the New 2026 Mammogram Guidelines Actually Say
The American College of Physicians released updated guidance on April 17, 2026, recommending that all asymptomatic, average-risk women ages 50 to 74 receive biennial (every two years) mammography screening for breast cancer.
For women 40 to 49, the ACP’s position is more nuanced. The guidance states that potential harms in this age group, including false positives, psychological distress, overdiagnosis, overtreatment and radiation exposure, may outweigh the uncertain benefits of screening. Rather than a blanket recommendation, the ACP says this decision should be made individually with your doctor.
Why Mammogram Guidelines Keep Changing and Which Organizations Disagree
The confusion isn’t new. Four major medical organizations, four different recommendations:
- ACP (2026): Biennial screening, ages 50 to 74; individualized decisions for ages 40 to 49
- U.S. Preventive Services Task Force: Biennial screening starting at age 40, through age 74
- American Cancer Society: Annual mammograms ages 45 to 54; women 55 and older can switch to every other year
- American College of Radiology and Society of Breast Imaging: Annual screening starting at age 40, calling the ACP guidance potentially life-threatening
The ACR warned that limiting screening to women 50 to 74 every other year could result in thousands of additional preventable breast cancer deaths each year.
The False Positive Risk That’s Driving the Biennial Mammogram Debate
One of the core reasons the ACP backs biennial screening is the false positive rate. About 80% of U.S. women aged 50 to 74 currently undergo biennial mammography, meaning most women in that age group are already aligned with the new ACP guidance.
A false positive means getting called back for additional imaging or a biopsy that ultimately shows no cancer. That process carries real costs: anxiety, additional procedures and time. The ACP argues that spacing out screenings reduces those experiences without meaningfully reducing survival benefit. The ACR counters that false positive anxiety is typically brief and shouldn’t be weighted so heavily against early detection.
What “Average Risk” Means for Breast Cancer Screening
The ACP’s updated guidance applies specifically to average-risk women. You’re considered average risk if you don’t have:
- A personal history of breast cancer or a high-risk breast lesion
- A known BRCA1 or BRCA2 gene mutation
- A strong family history of breast cancer
- A history of high-dose chest radiation at a young age
If any of those apply to you, talk to your doctor about a personalized screening schedule. High-risk women are often advised to begin annual screening as early as age 30, and may also need breast MRI.
What Women With Dense Breasts Should Know About Mammogram Screening
For women with dense breasts, the ACP advises doctors to consider supplemental digital breast tomosynthesis (3D mammography), while advising against supplemental MRI or ultrasound for average-risk individuals. The ACR’s position is stricter: it supports additional imaging for women with dense tissue, noting that mammography alone may miss cancers in this group.
If you’ve been told you have dense breast tissue, it’s worth asking your doctor specifically whether supplemental screening makes sense for you.
How Often Should You Get a Mammogram? Here’s What Experts Say
Whatever your age, the most important thing is that you’re being screened. The organizations debating frequency all agree on that. What differs is how they weigh early detection against the risks of over-screening.
- If you’re 50 to 74: the ACP, USPSTF and most internists support every-two-year screening
- If you’re 40 to 49: have a direct conversation with your doctor about your personal risk
- If you’re 75 or older: discuss with your doctor whether continuing makes sense given your overall health
Guidelines will keep shifting as research evolves, but having a clear, honest conversation with your provider, ideally one who knows your family history, is the most reliable way to figure out the right schedule for you.
This article was created by content specialists using various tools, including AI.
